Highlights from ASCO: A recently published study could change the practice of how prostate cancer is treated.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
In this video, Jorge A. Garcia, MD
., FACP., staff physician in Cleveland Clinic’s Genitourinary Oncology Program, talks about the impact of the recently published Phase III Randomized Study of Chemohormonal Therapy Versus Androgen Ablation Therapy in Patients With Extensive Metastatic Prostate Cancer
and how he thinks this will impact the care patients receive.